Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Baxter
QuintilesIMS
Merck
Covington
Argus Health
Cantor Fitzgerald
Moodys
Chubb
Boehringer Ingelheim

Generated: August 17, 2017

DrugPatentWatch Database Preview

Cadista Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for CADISTA PHARMS, and what generic and branded alternatives to CADISTA PHARMS drugs are available?

CADISTA PHARMS has two approved drugs.



Summary for Applicant: Cadista Pharms

Patents:0
Tradenames:2
Ingredients:2
NDAs:2
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cadista Pharms
LOSARTAN POTASSIUM
losartan potassium
TABLET;ORAL201170-003Sep 18, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Cadista Pharms
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; losartan potassium
TABLET;ORAL201845-001Sep 18, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Cadista Pharms
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; losartan potassium
TABLET;ORAL201845-003Sep 18, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Cadista Pharms
LOSARTAN POTASSIUM
losartan potassium
TABLET;ORAL201170-001Sep 18, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Cadista Pharms
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; losartan potassium
TABLET;ORAL201845-002Sep 18, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Dow
US Department of Justice
Healthtrust
Express Scripts
Merck
Queensland Health
AstraZeneca
Julphar
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot